The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

The prostate is a small organ that sits under the bladder in men, and provides a nourishing fluid that helps transport sperm. It often enlarges as men age, most commonly as benign tissue growth — ...

Screening with the prostate-specific antigen (PSA) test can detect early-stage prostate cancer while it's still asymptomatic. But some men are diagnosed with prostate cancer only after symptoms appear ...

According to the American Cancer Society, Black men are one and a half times more likely to get prostate cancer than Caucasian men. And if Black men develop prostate cancer, they are twice as likely ...

During September’s Prostate Cancer Awareness Month, MidLantic Urology is reminding men of a critical point. It's 0.75. If your PSA increases by 0.75 in 1 year, it could be prostate cancer, and it’s ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

If you're experiencing symptoms that may indicate prostate cancer, here's what else could be causing them getty Several medical conditions can mimic prostate cancer, causing many of the same symptoms, ...

At a median follow-up of 21.5 months, ADT plus apalutamide significantly prolonged median PSA progression-free survival compared with ADT monotherapy (24.9 vs 20.3 months; hazard ratio [HR], 0.52).